A newborn infant with an acute metabolic encephalopathy caused by isovaleric acidaemia had severe impairment of cerebral energy metabolism. This was detected by phosphorus and proton magnetic resonance spectroscopy. After treatment she made excellent clinical recovery, her spectroscopic abnormalities resolved, and she was neurologically normal at the age of 1 year. (Arch Dis Child 1996; 74: F21 1-F2 13) 
Isovaleric acidaemia is a rare inborn error of organic acid metabolism, caused by deficiency of isovaleryl CoA dehydrogenase. Some patients present in the neonatal period with a progressive encephalopathy and non-specific symptoms such as poor feeding, weight loss, and vomiting. The characteristic odour of 'sweaty feet' may feature. The mechanism for the encephalopathy is not known, but raised concentrations of isovalerate and hyperammonaemia are likely to be important. The effect of these may be mediated through disordered mitochondrial metabolism, so we assessed cerebral metabolism before and after treatment in an acutely sick neonate with isovaleric acidaemia using phosphorus (31P) and proton (1H) magnetic resonance spectroscopy (MRS).
Case report A girl was born to non-consanguineous African parents by caesarean section following prolonged rupture of the fetal membranes and induction of labour at 37 weeks of gestation.
Her birthweight was 3T5 kg. She was initially in good condition (Apgar scores of 7 at one and 10 at five minutes), but at 3 days of age, poor feeding, vomiting, and weight loss necessitated transfer to the neonatal intensive care unit. On admission she was hypotonic, hypothermic (rectal temperature 345°C), and lethargic with signs of respiratory distress and severe dehydration. The blood glucose concentration was less than 2 mmolIl and the venous blood pH was 7-18, with a base deficit of -156 mmol/l. She was resuscitated with intravenous glucose, albumin, and sodium bicarbonate solutions and given broad spectrum antibiotics. Intravenous calcium gluconate was administered because plasma calcium was 1-34 mmol/l (plasma albumin 37 mmol/l). The plasma ammonia was 144 ,umol/l. At about 95 hours of age, the infant became apnoeic, and required ventilation in addition to further calcium and bicarbonate. The head ultrasound appearance suggested cerebral oedema. Isovaleric acidaemia was provisionally diagnosed because of the characteristic odour, and an intravenous infusion of camitine was started at 200 mg/kg/l over 24 hours, to reduce intracellular isovaleryl-Co A. Subsequent gas chromatography of urine with confirmation by mass spectrometry showed a large peak of isovaleric acid (2-4 mmol/mmol creatinine), isovaleryl glycine, and other conjugates, confirming the diagnosis.
At the age of 108 hours the first 31P and 'H MRS studies of the brain were performed, using a specialised transport incubator to maintain intensive support throughout the procedure.' The infant was subsequently transferred to Great Ormond Street Hospital for Sick Children where treatment with sodium bicarbonate, calcium, and a-calcidol was administered, in addition to a dopamine infusion for circulatory support. After a further five days, her level of consciousness improved and the neurological abnormalities resolved. The baby was discharged home on reduced protein intake, supplemented with glucose polymer and carnitine. The second MRS studies were carried out at 18 days of age.
At 1 year of age the infant underwent a neurological examination (Amiel-Tilson) and neurodevelopmental assessment (Griffiths).
MAGNETIC RESONANCE SPECTROSCOPY
Brain spectra were acquired using a 2 ' Results Figure 1A shows the brain IH spectrum obtained at 108 hours of age. In addition to the detection of major peaks due to choline containing compounds (cho), creatine (Cr;
including phosphocreatine (PCr)), and Nacetyl aspartate (NAA), several abnormalities were present.
The broad peak at 2-3 ppm, due mainly to glutamate and glutamine, had a peak area 1-4 times that of (NAA) at about 2-0 ppm. This ratio was more than five standard deviations above the mean of age matched controls. The lactate:NAA peak area ratio (0 5) was also raised compared with age matched controls. 5 The peak at 0 9 ppm (U) was possibly attributable to isovaleric acid, and a peak at about 1-5 ppm was probably alanine. High resolution IH MRS of cerebrospinal fluid (CSF) taken at 96 hours of age (fig 2) showed raised isovalerate concentrations at 0 9 ppm, confirming the in vivo assignment, as well as acetone and acetoacetate (2-2-2-3 ppm), and 3-hydroxybutyrate (1 2 ppm). Inositol and glucose were also present. The 31p spectrum acquired invivo at 108 hours of age ( fig 1B) revealed a major impairment of oxidative phosphorylation, as judged by the severely reduced [PCr]: [inorganic phosphate (Pi)] ratio of 0 37 (control data have 95% confidence limits 0-70 to 1-36).5
In the second cerebral MRS study, performed at 18 days of age, both 1H and 31p spectra had returned to normal (figs 3A and B); the lactate:NAA peak area ratio had fallen to 0-22 and the [PCr]: [Pi] was 1 72, indicating normal cerebral energy metabolism. Intracellular pH remained normal; it was 7-14 at 108 hours and 7-18 at 18 days.
At 1 year of age neurological assessment was normal, and the Griffiths quotient was, overall, within the normal range, but with some subscore variability.
Discussion
We have demonstrated profound abnormalities of cerebral metabolism in a newborn infant with acute encephalopathy due to isovaleric acidaemia. The acute metabolic encephalopathy is likely to be multifactorial7; in this case the infant was initially hypoglycaemic and acidotic with a mildly raised ammonia, as well (Cady EB, unpublished data) , implying that the impairment of energy metabolism had resolved by 18 days of age. We have already seen catastrophic failure of cerebral energy generation and subsequent death in two infants; one with argininosuccinic aciduria and one with propionic acidaemia.13 However, in the infant described here the spectroscopic abnormalities resolved two weeks after the start of treatment, suggesting that no permanent injury had occurred. This study shows that in isovaleric acidaemia, while many factors may contribute to the encephalopathy, these are potentially reversible, provided that the production and accumulation of toxic metabolites can be attenuated -for example, by removal of isovalerate as isovalerylcarnitine -and that measures are taken to protect cerebral perfusion and provide substrate for energy production early in the encephalopathy. Thus damage caused by release of excitatory neurotransmitters (with consequent cellular damage and programmed cell death) will not be initiated. These observations also show the potential of 31P and 1H MRS in acute neonatal encephalopathy to investigate abnormal cerebral metabolism, as well as provide diagnostic information. MRS could also be used to monitor response to treatment, and hence help determine optimal treatment of some inborn errors of metabolism.
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